INNUREX Trademark

Trademark Overview


On Thursday, March 4, 2004, a trademark application was filed for INNUREX with the United States Patent and Trademark Office. The USPTO has given the INNUREX trademark a serial number of 78378648. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 26, 2014. This trademark is owned by Oxford BioMedica plc. The INNUREX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical and biochemical products for use in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease

Gene therapy and prophylaxis products, pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; vector production technologies and neurogenomics products in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; Chemical products for use in medical science for the treatment of diseases of the eye, vascular and neo-vascularisition disorders, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation *and ...
innurex

General Information


Serial Number78378648
Word MarkINNUREX
Filing DateThursday, March 4, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 26, 2014
Registration Number3431115
Registration DateTuesday, May 20, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2005

Trademark Statements


Certificate of Correction for RegistrationIn the heading, delete class 42. Statement(s): Column 2, line 2, after "technologies" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 4, after "products" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 13 after "vascularisation" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" should be inserted.
Certificate of Correction for RegistrationIn the statement, Page 2, Column 1, line 15, after "Vascularisation" and injuries of the nervous, system, all should be inserted.
Goods and ServicesChemical and biochemical products for use in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease
Goods and ServicesGene therapy and prophylaxis products, pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; vector production technologies and neurogenomics products in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; Chemical products for use in medical science for the treatment of diseases of the eye, vascular and neo-vascularisition disorders, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation *and injuries of the nervous, system all* in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; pharmaceutical and biochemical preparations for the treatment of damaged nerves and spinal injuries and for the induction of nerve re-growth; medical instruments and apparatus for the administration of gene and antibody-based therapy and prophylactics, preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 26, 2014
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 26, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford BioMedica plc
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxford OX4 4GA
GB

Trademark Events


Event DateEvent Description
Friday, December 26, 2014CANCELLED SEC. 8 (6-YR)
Monday, June 1, 2009CORRECTION UNDER SECTION 7 ¿ PROCESSED
Tuesday, January 6, 2009ASSIGNED TO PARALEGAL
Wednesday, December 17, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 17, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 9, 2008TEAS SECTION 7 REQUEST RECEIVED
Monday, September 15, 2008CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, September 15, 2008ASSIGNED TO PARALEGAL
Tuesday, May 20, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, April 16, 2008TTAB RELEASE CASE TO TRADEMARKS
Wednesday, April 16, 2008OPPOSITION TERMINATED NO. 999999
Wednesday, April 16, 2008OPPOSITION DISMISSED NO. 999999
Tuesday, March 4, 2008PAPER RECEIVED
Thursday, March 9, 2006OPPOSITION INSTITUTED NO. 999999
Thursday, December 8, 2005EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 8, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2005NOTICE OF PUBLICATION
Thursday, September 22, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 16, 2005ASSIGNED TO LIE
Tuesday, September 13, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 13, 2005EXAMINER'S AMENDMENT ENTERED
Tuesday, September 13, 2005EXAMINERS AMENDMENT MAILED
Tuesday, September 13, 2005EXAMINERS AMENDMENT -WRITTEN
Friday, September 9, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 22, 2005WITHDRAWN BEFORE PUBLICATION
Tuesday, May 24, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 20, 2005ASSIGNED TO LIE
Tuesday, May 17, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 22, 2004NON-FINAL ACTION MAILED
Tuesday, September 21, 2004NON-FINAL ACTION WRITTEN
Monday, September 20, 2004ASSIGNED TO EXAMINER
Friday, March 19, 2004NEW APPLICATION ENTERED IN TRAM